Corteva, through its Corteva Catalyst platform launched in 2024, serves as the corporate venture and strategic investment arm of Corteva Agriscience, a publicly traded global agriculture company. The platform makes equity investments and forms strategic partnerships in agricultural technology startups, focusing on gene editing, biologicals and natural products, technology platforms, and decision science, with typical check sizes of $10 million or less across stages from pre-seed through Series C.
56% of their portfolio is in Food & Agriculture. They made 4 investments in the last 12 months. Average disclosed round size is $48.1M (across 13 rounds with reported amounts).
Portfolio
14
Fund Size
—
Top Stage
Series A
Last 12 Mo
4
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Tropic | Series C | $105M | Dec 2026 |
 Tropic | Series C | $105M | Mar 2026 |
| Tropic | Series C | $105M | Mar 2026 |
 Tropic Biosciences | Bridge | $105M | Mar 2026 |
 IBI Ag | Series A | $10M | Nov 2025 |
| SSymbiomics | Series A | — | Jan 2025 |
 Micropep | Series B | $40M | Sep 2024 |
| MMicropep Technologies | Series B | $29M | Sep 2024 |
 Micropep | Series B | $40M | Sep 2024 |
 Pairwise | Series C | $40M | Sep 2024 |
 SOLASTA Bio | Series A | $14M | Sep 2024 |
 Resurrect Bio | Series A | $8.1M | — |
 Ascribe Bioscience | Series A | $12M | — |
 Rainbow Crops | Seed | — | — |
| AAscribe Bio | Series A | $12M | — |
| AAscribe Bio | Seed | — | — |
Top Co-Investors
Last updated: 20 October 2026